Zdrowie i gospodarka · 26/09/2014

FDA Reopens Comment Period for Draft Informed Consent Information Sheet Guidance Document

The Food and Drug Administration (FDA) is reopening the comment period for the draft guidance document 'Informed Consent Information Sheet' to update comments and receive new information. The reopening follows a notice of availability published in the Federal Register on July 15, 2014.